Pain modulation: expectation, opioid analgesia and virtual pain.

To summarize, although there are multiple potential target nuclei for modulating pain transmission and several candidate efferent pathways that exert modulatory control, the most completely described pain modulating circuit includes the amygdala, PAG, DLPT and RVM in the brainstem. Through descending projections, this circuit controls both spinal and trigeminal dorsal horn pain transmission neurons and mediates both opioid and stimulation produced analgesia. Several different neurotransmitters are involved in the modulatory actions of this circuit, which exerts bi-directional control of pain through On cells that facilitate and Off cells that inhibit dorsal horn nociceptive neurons. There is evidence that this circuit contributes to analgesia in humans and may be activated by acute stress or the expectation of relief. Conversely, through the facilitating effect of On cells, this circuit is theoretically capable of generating or enhancing perceived pain intensity. Such an effect could provide a physiological mechanism for the pain enhancing actions of mood, attention and expectation.

[1]  M. Goedert,et al.  Endogenous opioid peptides. , 1981, Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg.

[2]  H. Fields,et al.  Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla. , 1995, Journal of neurophysiology.

[3]  P. Mason,et al.  Neurotransmitters in nociceptive modulatory circuits. , 1991, Annual review of neuroscience.

[4]  G. Holstege.  Direct and indirect pathways to lamina I in the medulla oblongata and spinal cord of the cat. , 1988, Progress in brain research.

[5]  Paul Taenzer,et al.  Influence of psychological factors on postoperative pain, mood and analgesic requirements , 1986, Pain.

[6]  L. Krasner,et al.  THE PLACEBO RESPONSE: AN EXPERIMENTAL APPROACH , 1963, The Journal of nervous and mental disease.

[7]  P. Baer,et al.  Situational and psychophysiological factors in psychologically induced pain , 1991, Pain.

[8]  P. Emson,et al.  Regional distribution of pro-opiomelanocortin-derived peptides in the human brain. , 1984, Neuroendocrinology.

[9]  L. Watkins,et al.  The neural basis of footshock analgesia: The role of specific ventral medullary nuclei , 1983, Brain Research.

[10]  H. Fields,et al.  Endogenous opioid peptides acting at mu-opioid receptors in the dorsal horn contribute to midbrain modulation of spinal nociceptive neurons. , 1998, Journal of neurophysiology.

[11]  FJ Helmstetter,et al.  Lesions of the periaqueductal gray and rostral ventromedial medulla disrupt antinociceptive but not cardiovascular aversive conditional responses , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[12]  P. Bellgowan,et al.  Inhibition of the tail flick reflex following microinjection of morphine into the amygdala. , 1993, NeuroReport.

[13]  C. Cleeland,et al.  The effects of induced mood on laboratory pain , 1991, Pain.

[14]  Y. Hosobuchi,et al.  Autopsy analysis of the safety, efficacy and cartography of electrical stimulation of the central gray in humans , 1986, Brain Research.

[15]  H. Fields,et al.  THE MECHANISM OF PLACEBO ANALGESIA , 1978, The Lancet.

[16]  J. Dostrovsky,et al.  Phantom sensations generated by thalamic microstimulation , 1998, Nature.

[17]  H. Fields,et al.  Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla , 1994, Neuroscience.

[18]  E. Laska,et al.  ANTICIPATION OF ANALGESIA, A PLACEBO EFFECT , 1973, Headache.

[19]  M. Fanselow,et al.  Effects of amygdala, hippocampus, and periaqueductal gray lesions on short- and long-term contextual fear. , 1993, Behavioral neuroscience.

[20]  M. Bushnell,et al.  Attentional influences on noxious and innocuous cutaneous heat detection in humans and monkeys , 1985 .

[21]  M. Bushnell,et al.  Effects of attention on the intensity and unpleasantness of thermal pain , 1989, Pain.

[22]  F. Benedetti,et al.  THE NEUROBIOLOGY OF PLACEBO ANALGESIA: FROM ENDOGENOUS OPIOIDS TO CHOLECYSTOKININ , 1997, Progress in Neurobiology.

[23]  L. Jasmin,et al.  An Opioidergic Cortical Antinociception Triggering Site in the Agranular Insular Cortex of the Rat that Contributes to Morphine Antinociception , 1996, The Journal of Neuroscience.

[24]  Patrick D. Wall,et al.  Acute pain in an emergency clinic: Latency of onset and descriptor patterns related to different injuries , 1982, Pain.

[25]  L. Villanueva,et al.  Distribution of spinal cord projections from the medullary subnucleus reticularis dorsalis and the adjacent cuneate nucleus: A phaseolus vulgaris‐ leucoagglutinin study in the rat , 1995, The Journal of comparative neurology.

[26]  A. Stewart,et al.  The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. , 1989, JAMA.

[27]  B. Seizinger,et al.  Distribution and characterization of opioid peptides derived from proenkephalin A in human and rat central nervous system , 1984, Brain Research.

[28]  A I Basbaum,et al.  Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. , 1984, Annual review of neuroscience.

[29]  N. Breslau,et al.  Migraine, psychiatric disorders, and suicide attempts: An epidemiologic study of young adults , 1991, Psychiatry Research.

[30]  J. Levine,et al.  Influence of the method of drug administration on analgesic response , 1984, Nature.

[31]  J. R Gibbs,et al.  TREATMENT OF EXCESSIVE AXILLARY SWEATING , 1974 .

[32]  M. Bushnell,et al.  Task-related responses of monkey medullary dorsal horn neurons. , 1987, Journal of neurophysiology.

[33]  R. Bodnar,et al.  Medullary μ and δ opioid receptors modulate mesencephalic morphine analgesia in rats , 1993, Brain Research.

[34]  R. Liberman,et al.  AN EXPERIMENTAL STUDY OF THE PLACEBO RESPONSE UNDER THREE DIFFERENT SITUATIONS OF PAIN. , 1964, Journal of psychiatric research.

[35]  M. Fanselow.  The Midbrain Periaqueductal Gray as a Coordinator of Action in Response to Fear and Anxiety , 1991 .

[36]  Q. Ma,et al.  Naloxone blocks opioid peptide release in N. accumbens and amygdala elicited by morphine injected into periaqueductal gray. , 1992, Brain research bulletin.

[37]  L. Watkins,et al.  Organization of endogenous opiate and nonopiate pain control systems. , 1982, Science.

[38]  H. Fields,et al.  Role of pain in placebo analgesia. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Nicholas J. Voudouris,et al.  The role of conditioning and verbal expectancy in the placebo response , 1990, Pain.

[40]  D. Ziegler,et al.  Headache symptoms and psychological profile of headache-prone individuals. A comparison of clinic patients and controls. , 1995, Archives of neurology.

[41]  K. Merikangas,et al.  Migraine and psychopathology. Results of the Zurich cohort study of young adults. , 1990, Archives of general psychiatry.

[42]  Myron Goldberg,et al.  Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria , 1986, Pain.

[43]  H. Fields,et al.  The narcotic antagonist naloxone enhances clinical pain , 1978, Nature.

[44]  R. Dubner,et al.  Placebo and naloxone can alter post-surgical pain by separate mechanisms , 1983, Nature.

[45]  H. Fields,et al.  Endogenous opioids acting at a medullary μ-opioid receptor contribute to the behavioral antinociception produced by GABA antagonism in the midbrain periaqueductal gray , 1996, Neuroscience.